nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—Clobazam—epilepsy syndrome	0.131	0.518	CrCtD
Clomipramine—Diazepam—epilepsy syndrome	0.122	0.482	CrCtD
Clomipramine—panic disorder—Diazepam—epilepsy syndrome	0.11	0.623	CpDpCtD
Clomipramine—panic disorder—Clonazepam—epilepsy syndrome	0.0669	0.377	CpDpCtD
Clomipramine—ADRA2A—epilepsy syndrome	0.0314	0.228	CbGaD
Clomipramine—SLC6A4—epilepsy syndrome	0.024	0.174	CbGaD
Clomipramine—CYP2C19—epilepsy syndrome	0.0227	0.165	CbGaD
Clomipramine—HTR2A—epilepsy syndrome	0.0184	0.134	CbGaD
Clomipramine—CYP2D6—epilepsy syndrome	0.0168	0.122	CbGaD
Clomipramine—ALB—epilepsy syndrome	0.0126	0.0914	CbGaD
Clomipramine—ABCB1—epilepsy syndrome	0.012	0.0872	CbGaD
Clomipramine—ALB—Oxcarbazepine—epilepsy syndrome	0.00751	0.0524	CbGbCtD
Clomipramine—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.00663	0.04	CrCrCtD
Clomipramine—ALB—Fosphenytoin—epilepsy syndrome	0.00656	0.0458	CbGbCtD
Clomipramine—Doxepin—Oxcarbazepine—epilepsy syndrome	0.00598	0.0361	CrCrCtD
Clomipramine—Adinazolam—Midazolam—epilepsy syndrome	0.00598	0.0361	CrCrCtD
Clomipramine—ALB—Clonazepam—epilepsy syndrome	0.00594	0.0414	CbGbCtD
Clomipramine—Flurazepam—Clonazepam—epilepsy syndrome	0.0059	0.0356	CrCrCtD
Clomipramine—Adinazolam—Clobazam—epilepsy syndrome	0.00574	0.0346	CrCrCtD
Clomipramine—Flurazepam—Midazolam—epilepsy syndrome	0.00563	0.034	CrCrCtD
Clomipramine—Desipramine—Carbamazepine—epilepsy syndrome	0.00561	0.0339	CrCrCtD
Clomipramine—Flurazepam—Clobazam—epilepsy syndrome	0.00539	0.0326	CrCrCtD
Clomipramine—Adinazolam—Diazepam—epilepsy syndrome	0.00533	0.0322	CrCrCtD
Clomipramine—Clobazam—Oxcarbazepine—epilepsy syndrome	0.00517	0.0312	CrCrCtD
Clomipramine—Desipramine—Oxcarbazepine—epilepsy syndrome	0.00517	0.0312	CrCrCtD
Clomipramine—Clobazam—Midazolam—epilepsy syndrome	0.00517	0.0312	CrCrCtD
Clomipramine—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.00504	0.0304	CrCrCtD
Clomipramine—Flurazepam—Diazepam—epilepsy syndrome	0.00501	0.0303	CrCrCtD
Clomipramine—Trimipramine—Carbamazepine—epilepsy syndrome	0.00496	0.0299	CrCrCtD
Clomipramine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00487	0.0339	CbGbCtD
Clomipramine—ALB—Rufinamide—epilepsy syndrome	0.00484	0.0337	CbGbCtD
Clomipramine—Dimetacrine—Carbamazepine—epilepsy syndrome	0.00475	0.0286	CrCrCtD
Clomipramine—Diazepam—Clonazepam—epilepsy syndrome	0.00468	0.0283	CrCrCtD
Clomipramine—Clobazam—Diazepam—epilepsy syndrome	0.00461	0.0278	CrCrCtD
Clomipramine—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.00457	0.0276	CrCrCtD
Clomipramine—Imipramine—Carbamazepine—epilepsy syndrome	0.00455	0.0275	CrCrCtD
Clomipramine—CYP2C19—Felbamate—epilepsy syndrome	0.00453	0.0316	CbGbCtD
Clomipramine—CYP2C19—Trimethadione—epilepsy syndrome	0.00453	0.0316	CbGbCtD
Clomipramine—Diazepam—Midazolam—epilepsy syndrome	0.00447	0.027	CrCrCtD
Clomipramine—Diazepam—Oxcarbazepine—epilepsy syndrome	0.00447	0.027	CrCrCtD
Clomipramine—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.00437	0.0264	CrCrCtD
Clomipramine—ABCB1—Levetiracetam—epilepsy syndrome	0.0043	0.0299	CbGbCtD
Clomipramine—Diazepam—Clobazam—epilepsy syndrome	0.00428	0.0259	CrCrCtD
Clomipramine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00426	0.0297	CbGbCtD
Clomipramine—ALB—Phenytoin—epilepsy syndrome	0.00423	0.0295	CbGbCtD
Clomipramine—Promethazine—Carbamazepine—epilepsy syndrome	0.00421	0.0254	CrCrCtD
Clomipramine—Imipramine—Oxcarbazepine—epilepsy syndrome	0.00419	0.0253	CrCrCtD
Clomipramine—Chlorprothixene—Midazolam—epilepsy syndrome	0.00419	0.0253	CrCrCtD
Clomipramine—Alimemazine—Carbamazepine—epilepsy syndrome	0.00413	0.0249	CrCrCtD
Clomipramine—ALB—Propofol—epilepsy syndrome	0.00394	0.0275	CbGbCtD
Clomipramine—Promethazine—Oxcarbazepine—epilepsy syndrome	0.00388	0.0234	CrCrCtD
Clomipramine—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.00381	0.023	CrCrCtD
Clomipramine—Chlorpromazine—Clobazam—epilepsy syndrome	0.00379	0.0229	CrCrCtD
Clomipramine—Chlorprothixene—Diazepam—epilepsy syndrome	0.00374	0.0226	CrCrCtD
Clomipramine—CYP2C19—Clobazam—epilepsy syndrome	0.00369	0.0257	CbGbCtD
Clomipramine—ALB—Diazepam—epilepsy syndrome	0.00357	0.0249	CbGbCtD
Clomipramine—Promazine—Carbamazepine—epilepsy syndrome	0.00356	0.0215	CrCrCtD
Clomipramine—Prochlorperazine—Clobazam—epilepsy syndrome	0.0034	0.0205	CrCrCtD
Clomipramine—Promazine—Oxcarbazepine—epilepsy syndrome	0.00328	0.0198	CrCrCtD
Clomipramine—CYP2C19—Carbamazepine—epilepsy syndrome	0.00306	0.0213	CbGbCtD
Clomipramine—ABCB1—Clobazam—epilepsy syndrome	0.00298	0.0208	CbGbCtD
Clomipramine—ABCB1—Lamotrigine—epilepsy syndrome	0.00287	0.02	CbGbCtD
Clomipramine—CYP2C19—Primidone—epilepsy syndrome	0.00285	0.0199	CbGbCtD
Clomipramine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00282	0.0197	CbGbCtD
Clomipramine—CYP2C19—Phenytoin—epilepsy syndrome	0.00274	0.0191	CbGbCtD
Clomipramine—CYP1A2—Primidone—epilepsy syndrome	0.00263	0.0184	CbGbCtD
Clomipramine—CYP2C19—Propofol—epilepsy syndrome	0.00256	0.0178	CbGbCtD
Clomipramine—ABCB1—Carbamazepine—epilepsy syndrome	0.00247	0.0172	CbGbCtD
Clomipramine—CYP2C19—Phenobarbital—epilepsy syndrome	0.00244	0.017	CbGbCtD
Clomipramine—CYP1A2—Propofol—epilepsy syndrome	0.00236	0.0165	CbGbCtD
Clomipramine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00235	0.0164	CbGbCtD
Clomipramine—CYP2C19—Diazepam—epilepsy syndrome	0.00232	0.0162	CbGbCtD
Clomipramine—CYP2C19—Zonisamide—epilepsy syndrome	0.00226	0.0158	CbGbCtD
Clomipramine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00226	0.0157	CbGbCtD
Clomipramine—ABCB1—Phenytoin—epilepsy syndrome	0.00221	0.0154	CbGbCtD
Clomipramine—CYP3A4—Felbamate—epilepsy syndrome	0.00219	0.0153	CbGbCtD
Clomipramine—CYP3A4—Trimethadione—epilepsy syndrome	0.00219	0.0153	CbGbCtD
Clomipramine—CYP1A2—Diazepam—epilepsy syndrome	0.00214	0.0149	CbGbCtD
Clomipramine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00206	0.0143	CbGbCtD
Clomipramine—ABCB1—Phenobarbital—epilepsy syndrome	0.00197	0.0138	CbGbCtD
Clomipramine—ABCB1—Midazolam—epilepsy syndrome	0.00194	0.0136	CbGbCtD
Clomipramine—CYP2D6—Propofol—epilepsy syndrome	0.00194	0.0136	CbGbCtD
Clomipramine—ABCB1—Diazepam—epilepsy syndrome	0.00187	0.013	CbGbCtD
Clomipramine—CYP3A4—Clonazepam—epilepsy syndrome	0.00186	0.013	CbGbCtD
Clomipramine—CYP2C19—Valproic Acid—epilepsy syndrome	0.00183	0.0127	CbGbCtD
Clomipramine—CYP3A4—Clobazam—epilepsy syndrome	0.00178	0.0124	CbGbCtD
Clomipramine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00169	0.0118	CbGbCtD
Clomipramine—CYP2C19—Topiramate—epilepsy syndrome	0.00165	0.0115	CbGbCtD
Clomipramine—CYP3A4—Rufinamide—epilepsy syndrome	0.00152	0.0106	CbGbCtD
Clomipramine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00148	0.0103	CbGbCtD
Clomipramine—HTR2A—phrenic nerve—epilepsy syndrome	0.0014	0.0842	CbGeAlD
Clomipramine—CYP3A4—Primidone—epilepsy syndrome	0.00138	0.00962	CbGbCtD
Clomipramine—CYP3A4—Phenytoin—epilepsy syndrome	0.00133	0.00924	CbGbCtD
Clomipramine—CYP3A4—Propofol—epilepsy syndrome	0.00124	0.00862	CbGbCtD
Clomipramine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00118	0.00824	CbGbCtD
Clomipramine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00118	0.00824	CbGbCtD
Clomipramine—CYP3A4—Midazolam—epilepsy syndrome	0.00117	0.00812	CbGbCtD
Clomipramine—CYP3A4—Diazepam—epilepsy syndrome	0.00112	0.00781	CbGbCtD
Clomipramine—CYP3A4—Zonisamide—epilepsy syndrome	0.00109	0.00762	CbGbCtD
Clomipramine—SLC6A2—locus ceruleus—epilepsy syndrome	0.00104	0.0625	CbGeAlD
Clomipramine—CYP3A4—Valproic Acid—epilepsy syndrome	0.000883	0.00616	CbGbCtD
Clomipramine—CYP3A4—Topiramate—epilepsy syndrome	0.000797	0.00555	CbGbCtD
Clomipramine—HTR6—ganglion—epilepsy syndrome	0.000635	0.0383	CbGeAlD
Clomipramine—HTR2A—locus ceruleus—epilepsy syndrome	0.000623	0.0376	CbGeAlD
Clomipramine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000589	0.0355	CbGeAlD
Clomipramine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000551	0.0332	CbGeAlD
Clomipramine—HTR2A—cerebellar cortex—epilepsy syndrome	0.000508	0.0306	CbGeAlD
Clomipramine—HTR2A—vagus nerve—epilepsy syndrome	0.000477	0.0288	CbGeAlD
Clomipramine—HTR2C—ganglion—epilepsy syndrome	0.000367	0.0221	CbGeAlD
Clomipramine—HTR2A—pons—epilepsy syndrome	0.000359	0.0217	CbGeAlD
Clomipramine—SLC6A4—ganglion—epilepsy syndrome	0.000348	0.021	CbGeAlD
Clomipramine—HTR2A—autonomic nervous system—epilepsy syndrome	0.000331	0.02	CbGeAlD
Clomipramine—SLC6A2—ganglion—epilepsy syndrome	0.000306	0.0185	CbGeAlD
Clomipramine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000296	0.0178	CbGeAlD
Clomipramine—HTR6—forebrain—epilepsy syndrome	0.000266	0.0161	CbGeAlD
Clomipramine—SLC6A4—hindbrain—epilepsy syndrome	0.000264	0.0159	CbGeAlD
Clomipramine—HTR6—telencephalon—epilepsy syndrome	0.000245	0.0148	CbGeAlD
Clomipramine—HTR2A—ganglion—epilepsy syndrome	0.000184	0.0111	CbGeAlD
Clomipramine—GSTP1—forebrain—epilepsy syndrome	0.000175	0.0106	CbGeAlD
Clomipramine—GSTP1—telencephalon—epilepsy syndrome	0.000161	0.00972	CbGeAlD
Clomipramine—HTR2C—brainstem—epilepsy syndrome	0.000159	0.00962	CbGeAlD
Clomipramine—HTR2C—forebrain—epilepsy syndrome	0.000154	0.00928	CbGeAlD
Clomipramine—HTR6—head—epilepsy syndrome	0.000152	0.0092	CbGeAlD
Clomipramine—SLC6A4—brainstem—epilepsy syndrome	0.000151	0.00912	CbGeAlD
Clomipramine—SLC6A4—forebrain—epilepsy syndrome	0.000146	0.0088	CbGeAlD
Clomipramine—HTR6—nervous system—epilepsy syndrome	0.000145	0.00872	CbGeAlD
Clomipramine—HTR2B—forebrain—epilepsy syndrome	0.000145	0.00872	CbGeAlD
Clomipramine—HTR2C—telencephalon—epilepsy syndrome	0.000141	0.00853	CbGeAlD
Clomipramine—HTR2A—hindbrain—epilepsy syndrome	0.00014	0.00842	CbGeAlD
Clomipramine—HRH2—head—epilepsy syndrome	0.000139	0.00841	CbGeAlD
Clomipramine—HTR6—central nervous system—epilepsy syndrome	0.000139	0.00839	CbGeAlD
Clomipramine—SLC6A4—telencephalon—epilepsy syndrome	0.000134	0.00809	CbGeAlD
Clomipramine—SLC6A2—brainstem—epilepsy syndrome	0.000133	0.00803	CbGeAlD
Clomipramine—HTR2B—telencephalon—epilepsy syndrome	0.000133	0.00802	CbGeAlD
Clomipramine—HRH2—nervous system—epilepsy syndrome	0.000132	0.00797	CbGeAlD
Clomipramine—SLC6A2—forebrain—epilepsy syndrome	0.000128	0.00775	CbGeAlD
Clomipramine—HRH2—central nervous system—epilepsy syndrome	0.000127	0.00767	CbGeAlD
Clomipramine—CYP2D6—hindbrain—epilepsy syndrome	0.000127	0.00767	CbGeAlD
Clomipramine—GSTP1—medulla oblongata—epilepsy syndrome	0.000127	0.00764	CbGeAlD
Clomipramine—SLC6A2—telencephalon—epilepsy syndrome	0.000118	0.00712	CbGeAlD
Clomipramine—GSTP1—midbrain—epilepsy syndrome	0.000116	0.00698	CbGeAlD
Clomipramine—GSTP1—spinal cord—epilepsy syndrome	0.000113	0.00681	CbGeAlD
Clomipramine—HTR2C—medulla oblongata—epilepsy syndrome	0.000111	0.00671	CbGeAlD
Clomipramine—HTR6—brain—epilepsy syndrome	0.00011	0.00666	CbGeAlD
Clomipramine—HTR2C—midbrain—epilepsy syndrome	0.000102	0.00613	CbGeAlD
Clomipramine—HRH2—brain—epilepsy syndrome	0.000101	0.00609	CbGeAlD
Clomipramine—GSTP1—head—epilepsy syndrome	0.0001	0.00605	CbGeAlD
Clomipramine—HTR2C—spinal cord—epilepsy syndrome	9.91e-05	0.00598	CbGeAlD
Clomipramine—SLC6A4—midbrain—epilepsy syndrome	9.63e-05	0.00581	CbGeAlD
Clomipramine—GSTP1—nervous system—epilepsy syndrome	9.51e-05	0.00574	CbGeAlD
Clomipramine—SLC6A4—spinal cord—epilepsy syndrome	9.4e-05	0.00567	CbGeAlD
Clomipramine—SLC6A2—medulla oblongata—epilepsy syndrome	9.28e-05	0.0056	CbGeAlD
Clomipramine—GSTP1—central nervous system—epilepsy syndrome	9.16e-05	0.00553	CbGeAlD
Clomipramine—ADRA2A—forebrain—epilepsy syndrome	9.08e-05	0.00548	CbGeAlD
Clomipramine—GSTP1—cerebellum—epilepsy syndrome	8.95e-05	0.0054	CbGeAlD
Clomipramine—HTR2C—head—epilepsy syndrome	8.81e-05	0.00531	CbGeAlD
Clomipramine—HTR2C—nervous system—epilepsy syndrome	8.35e-05	0.00504	CbGeAlD
Clomipramine—SLC6A4—head—epilepsy syndrome	8.35e-05	0.00504	CbGeAlD
Clomipramine—ADRA2A—telencephalon—epilepsy syndrome	8.35e-05	0.00503	CbGeAlD
Clomipramine—HTR2B—head—epilepsy syndrome	8.28e-05	0.00499	CbGeAlD
Clomipramine—HTR2C—central nervous system—epilepsy syndrome	8.04e-05	0.00485	CbGeAlD
Clomipramine—Olopatadine—S100B—epilepsy syndrome	8.02e-05	0.0468	CrCbGaD
Clomipramine—HTR2A—brainstem—epilepsy syndrome	8e-05	0.00482	CbGeAlD
Clomipramine—SLC6A4—nervous system—epilepsy syndrome	7.92e-05	0.00478	CbGeAlD
Clomipramine—HTR2B—nervous system—epilepsy syndrome	7.85e-05	0.00473	CbGeAlD
Clomipramine—HTR2A—forebrain—epilepsy syndrome	7.72e-05	0.00466	CbGeAlD
Clomipramine—SLC6A4—central nervous system—epilepsy syndrome	7.62e-05	0.0046	CbGeAlD
Clomipramine—HTR2B—central nervous system—epilepsy syndrome	7.55e-05	0.00456	CbGeAlD
Clomipramine—SLC6A2—head—epilepsy syndrome	7.35e-05	0.00444	CbGeAlD
Clomipramine—CYP2D6—brainstem—epilepsy syndrome	7.29e-05	0.00439	CbGeAlD
Clomipramine—GSTP1—brain—epilepsy syndrome	7.27e-05	0.00439	CbGeAlD
Clomipramine—HTR2A—telencephalon—epilepsy syndrome	7.1e-05	0.00428	CbGeAlD
Clomipramine—CYP2D6—forebrain—epilepsy syndrome	7.03e-05	0.00424	CbGeAlD
Clomipramine—SLC6A2—nervous system—epilepsy syndrome	6.97e-05	0.0042	CbGeAlD
Clomipramine—SLC6A2—central nervous system—epilepsy syndrome	6.71e-05	0.00405	CbGeAlD
Clomipramine—ADRA2A—medulla oblongata—epilepsy syndrome	6.56e-05	0.00396	CbGeAlD
Clomipramine—CYP2D6—telencephalon—epilepsy syndrome	6.47e-05	0.0039	CbGeAlD
Clomipramine—HTR2C—brain—epilepsy syndrome	6.38e-05	0.00385	CbGeAlD
Clomipramine—ALB—brain—epilepsy syndrome	6.23e-05	0.00376	CbGeAlD
Clomipramine—SLC6A4—brain—epilepsy syndrome	6.05e-05	0.00365	CbGeAlD
Clomipramine—HTR2B—brain—epilepsy syndrome	6e-05	0.00362	CbGeAlD
Clomipramine—ADRA2A—midbrain—epilepsy syndrome	5.99e-05	0.00362	CbGeAlD
Clomipramine—ADRA2A—spinal cord—epilepsy syndrome	5.85e-05	0.00353	CbGeAlD
Clomipramine—Clobazam—SLC6A1—epilepsy syndrome	5.6e-05	0.0327	CrCbGaD
Clomipramine—HTR2A—medulla oblongata—epilepsy syndrome	5.58e-05	0.00336	CbGeAlD
Clomipramine—SLC6A2—brain—epilepsy syndrome	5.33e-05	0.00321	CbGeAlD
Clomipramine—ADRA2A—head—epilepsy syndrome	5.2e-05	0.00313	CbGeAlD
Clomipramine—HTR2A—midbrain—epilepsy syndrome	5.1e-05	0.00307	CbGeAlD
Clomipramine—ABCB1—forebrain—epilepsy syndrome	5.06e-05	0.00305	CbGeAlD
Clomipramine—HTR2A—spinal cord—epilepsy syndrome	4.97e-05	0.003	CbGeAlD
Clomipramine—ADRA2A—nervous system—epilepsy syndrome	4.93e-05	0.00297	CbGeAlD
Clomipramine—ADRA2A—central nervous system—epilepsy syndrome	4.74e-05	0.00286	CbGeAlD
Clomipramine—ABCB1—telencephalon—epilepsy syndrome	4.65e-05	0.00281	CbGeAlD
Clomipramine—ADRA2A—cerebellum—epilepsy syndrome	4.64e-05	0.0028	CbGeAlD
Clomipramine—HTR2A—head—epilepsy syndrome	4.42e-05	0.00267	CbGeAlD
Clomipramine—HTR2A—nervous system—epilepsy syndrome	4.19e-05	0.00253	CbGeAlD
Clomipramine—HTR2A—central nervous system—epilepsy syndrome	4.03e-05	0.00243	CbGeAlD
Clomipramine—CYP2D6—head—epilepsy syndrome	4.03e-05	0.00243	CbGeAlD
Clomipramine—HTR2A—cerebellum—epilepsy syndrome	3.94e-05	0.00238	CbGeAlD
Clomipramine—CYP3A4—nervous system—epilepsy syndrome	3.88e-05	0.00234	CbGeAlD
Clomipramine—CYP2D6—nervous system—epilepsy syndrome	3.82e-05	0.0023	CbGeAlD
Clomipramine—ADRA2A—brain—epilepsy syndrome	3.77e-05	0.00227	CbGeAlD
Clomipramine—CYP3A4—central nervous system—epilepsy syndrome	3.73e-05	0.00225	CbGeAlD
Clomipramine—CYP2D6—central nervous system—epilepsy syndrome	3.67e-05	0.00222	CbGeAlD
Clomipramine—ABCB1—medulla oblongata—epilepsy syndrome	3.65e-05	0.0022	CbGeAlD
Clomipramine—Imipramine—KCND2—epilepsy syndrome	3.65e-05	0.0213	CrCbGaD
Clomipramine—Amitriptyline—KCND2—epilepsy syndrome	3.62e-05	0.0211	CrCbGaD
Clomipramine—CYP2D6—cerebellum—epilepsy syndrome	3.59e-05	0.00217	CbGeAlD
Clomipramine—Amitriptyline—KCNQ2—epilepsy syndrome	3.37e-05	0.0197	CrCbGaD
Clomipramine—Amitriptyline—KCNQ3—epilepsy syndrome	3.37e-05	0.0197	CrCbGaD
Clomipramine—ABCB1—midbrain—epilepsy syndrome	3.34e-05	0.00201	CbGeAlD
Clomipramine—ABCB1—spinal cord—epilepsy syndrome	3.26e-05	0.00197	CbGeAlD
Clomipramine—HTR2A—brain—epilepsy syndrome	3.2e-05	0.00193	CbGeAlD
Clomipramine—CYP2D6—brain—epilepsy syndrome	2.92e-05	0.00176	CbGeAlD
Clomipramine—ABCB1—head—epilepsy syndrome	2.9e-05	0.00175	CbGeAlD
Clomipramine—Adinazolam—GABRD—epilepsy syndrome	2.9e-05	0.0169	CrCbGaD
Clomipramine—Amitriptyline—NTRK2—epilepsy syndrome	2.87e-05	0.0167	CrCbGaD
Clomipramine—ABCB1—nervous system—epilepsy syndrome	2.75e-05	0.00166	CbGeAlD
Clomipramine—Clobazam—GABRG2—epilepsy syndrome	2.69e-05	0.0157	CrCbGaD
Clomipramine—ABCB1—central nervous system—epilepsy syndrome	2.64e-05	0.00159	CbGeAlD
Clomipramine—Flurazepam—GABRD—epilepsy syndrome	2.61e-05	0.0152	CrCbGaD
Clomipramine—ABCB1—cerebellum—epilepsy syndrome	2.58e-05	0.00156	CbGeAlD
Clomipramine—Dimetindene—CHRM2—epilepsy syndrome	2.36e-05	0.0137	CrCbGaD
Clomipramine—Cyamemazine—CHRM2—epilepsy syndrome	2.29e-05	0.0134	CrCbGaD
Clomipramine—Adinazolam—GABRG2—epilepsy syndrome	2.19e-05	0.0128	CrCbGaD
Clomipramine—ABCB1—brain—epilepsy syndrome	2.1e-05	0.00127	CbGeAlD
Clomipramine—Diazepam—GABRD—epilepsy syndrome	2.07e-05	0.0121	CrCbGaD
Clomipramine—Flurazepam—GABRG2—epilepsy syndrome	1.98e-05	0.0115	CrCbGaD
Clomipramine—Propericiazine—ADRA2A—epilepsy syndrome	1.96e-05	0.0114	CrCbGaD
Clomipramine—Triflupromazine—CHRM1—epilepsy syndrome	1.95e-05	0.0114	CrCbGaD
Clomipramine—Clobazam—GABRB2—epilepsy syndrome	1.9e-05	0.0111	CrCbGaD
Clomipramine—Clobazam—GABRA1—epilepsy syndrome	1.86e-05	0.0108	CrCbGaD
Clomipramine—Adinazolam—GABRA5—epilepsy syndrome	1.77e-05	0.0103	CrCbGaD
Clomipramine—Adinazolam—GABRB3—epilepsy syndrome	1.77e-05	0.0103	CrCbGaD
Clomipramine—Flurazepam—GABRB3—epilepsy syndrome	1.59e-05	0.00929	CrCbGaD
Clomipramine—Flurazepam—GABRA5—epilepsy syndrome	1.59e-05	0.00929	CrCbGaD
Clomipramine—Triflupromazine—CHRM2—epilepsy syndrome	1.59e-05	0.00929	CrCbGaD
Clomipramine—Diazepam—GABRG2—epilepsy syndrome	1.57e-05	0.00917	CrCbGaD
Clomipramine—Propiomazine—CHRM3—epilepsy syndrome	1.55e-05	0.00902	CrCbGaD
Clomipramine—Adinazolam—GABRB2—epilepsy syndrome	1.55e-05	0.00902	CrCbGaD
Clomipramine—Adinazolam—GABRA1—epilepsy syndrome	1.52e-05	0.00884	CrCbGaD
Clomipramine—Chlorprothixene—CHRM3—epilepsy syndrome	1.46e-05	0.00854	CrCbGaD
Clomipramine—Propiomazine—CHRM1—epilepsy syndrome	1.44e-05	0.00841	CrCbGaD
Clomipramine—Nortriptyline—CHRM3—epilepsy syndrome	1.44e-05	0.00838	CrCbGaD
Clomipramine—Flurazepam—GABRB2—epilepsy syndrome	1.39e-05	0.00813	CrCbGaD
Clomipramine—Flurazepam—GABRA1—epilepsy syndrome	1.37e-05	0.00797	CrCbGaD
Clomipramine—Chlorprothixene—CHRM1—epilepsy syndrome	1.37e-05	0.00796	CrCbGaD
Clomipramine—Prochlorperazine—CHRM2—epilepsy syndrome	1.35e-05	0.0079	CrCbGaD
Clomipramine—Nortriptyline—CHRM1—epilepsy syndrome	1.34e-05	0.00782	CrCbGaD
Clomipramine—Triflupromazine—BCHE—epilepsy syndrome	1.33e-05	0.00774	CrCbGaD
Clomipramine—Methotrimeprazine—CHRM3—epilepsy syndrome	1.32e-05	0.00771	CrCbGaD
Clomipramine—Promethazine—CHRM3—epilepsy syndrome	1.3e-05	0.0076	CrCbGaD
Clomipramine—Doxepin—CHRM3—epilepsy syndrome	1.29e-05	0.00752	CrCbGaD
Clomipramine—Diazepam—GABRA5—epilepsy syndrome	1.27e-05	0.00738	CrCbGaD
Clomipramine—Diazepam—GABRB3—epilepsy syndrome	1.27e-05	0.00738	CrCbGaD
Clomipramine—Methotrimeprazine—CHRM1—epilepsy syndrome	1.23e-05	0.00719	CrCbGaD
Clomipramine—Promethazine—CHRM1—epilepsy syndrome	1.21e-05	0.00709	CrCbGaD
Clomipramine—Doxepin—CHRM1—epilepsy syndrome	1.2e-05	0.00701	CrCbGaD
Clomipramine—Desipramine—CHRM3—epilepsy syndrome	1.18e-05	0.0069	CrCbGaD
Clomipramine—Propiomazine—CHRM2—epilepsy syndrome	1.18e-05	0.00687	CrCbGaD
Clomipramine—Amitriptyline—OPRD1—epilepsy syndrome	1.17e-05	0.00684	CrCbGaD
Clomipramine—Cyamemazine—HTR2A—epilepsy syndrome	1.15e-05	0.00669	CrCbGaD
Clomipramine—Promazine—CHRM3—epilepsy syndrome	1.15e-05	0.00668	CrCbGaD
Clomipramine—Chlorprothixene—CHRM2—epilepsy syndrome	1.11e-05	0.0065	CrCbGaD
Clomipramine—Diazepam—GABRB2—epilepsy syndrome	1.11e-05	0.00646	CrCbGaD
Clomipramine—Desipramine—CHRM1—epilepsy syndrome	1.1e-05	0.00644	CrCbGaD
Clomipramine—Nortriptyline—CHRM2—epilepsy syndrome	1.09e-05	0.00638	CrCbGaD
Clomipramine—Diazepam—GABRA1—epilepsy syndrome	1.09e-05	0.00633	CrCbGaD
Clomipramine—Carbinoxamine—CYP2C19—epilepsy syndrome	1.08e-05	0.00631	CrCbGaD
Clomipramine—Promazine—CHRM1—epilepsy syndrome	1.07e-05	0.00623	CrCbGaD
Clomipramine—Thioridazine—CHRM2—epilepsy syndrome	1.05e-05	0.00615	CrCbGaD
Clomipramine—Thioridazine—HTR7—epilepsy syndrome	1.05e-05	0.00612	CrCbGaD
Clomipramine—Chlorpromazine—CHRM3—epilepsy syndrome	1.01e-05	0.00588	CrCbGaD
Clomipramine—Methotrimeprazine—CHRM2—epilepsy syndrome	1.01e-05	0.00587	CrCbGaD
Clomipramine—Imipramine—CHRM3—epilepsy syndrome	1e-05	0.00585	CrCbGaD
Clomipramine—Amitriptyline—CHRM3—epilepsy syndrome	9.97e-06	0.00582	CrCbGaD
Clomipramine—Promethazine—CHRM2—epilepsy syndrome	9.92e-06	0.00579	CrCbGaD
Clomipramine—Doxepin—CHRM2—epilepsy syndrome	9.82e-06	0.00573	CrCbGaD
Clomipramine—Trifluoperazine—CHRM2—epilepsy syndrome	9.79e-06	0.00571	CrCbGaD
Clomipramine—Chlorphenamine—SLC6A4—epilepsy syndrome	9.71e-06	0.00566	CrCbGaD
Clomipramine—Perphenazine—HTR7—epilepsy syndrome	9.63e-06	0.00562	CrCbGaD
Clomipramine—Chlorpromazine—CHRM1—epilepsy syndrome	9.4e-06	0.00549	CrCbGaD
Clomipramine—Imipramine—CHRM1—epilepsy syndrome	9.36e-06	0.00546	CrCbGaD
Clomipramine—Amitriptyline—CHRM1—epilepsy syndrome	9.3e-06	0.00542	CrCbGaD
Clomipramine—Desipramine—CHRM2—epilepsy syndrome	9.01e-06	0.00525	CrCbGaD
Clomipramine—Thioridazine—ADRA2A—epilepsy syndrome	9e-06	0.00525	CrCbGaD
Clomipramine—Amitriptyline—OPRM1—epilepsy syndrome	8.97e-06	0.00523	CrCbGaD
Clomipramine—Trimipramine—ADRA2A—epilepsy syndrome	8.79e-06	0.00513	CrCbGaD
Clomipramine—Pipotiazine—CYP2C19—epilepsy syndrome	8.74e-06	0.0051	CrCbGaD
Clomipramine—Clobazam—CYP2C19—epilepsy syndrome	8.74e-06	0.0051	CrCbGaD
Clomipramine—Promazine—CHRM2—epilepsy syndrome	8.73e-06	0.00509	CrCbGaD
Clomipramine—Methotrimeprazine—ADRA2A—epilepsy syndrome	8.59e-06	0.00501	CrCbGaD
Clomipramine—Doxepin—ADRA2A—epilepsy syndrome	8.38e-06	0.00489	CrCbGaD
Clomipramine—Perphenazine—ADRA2A—epilepsy syndrome	8.26e-06	0.00482	CrCbGaD
Clomipramine—Carbinoxamine—CYP2D6—epilepsy syndrome	8.02e-06	0.00468	CrCbGaD
Clomipramine—Chlorpromazine—CHRM2—epilepsy syndrome	7.68e-06	0.00448	CrCbGaD
Clomipramine—Chlorpromazine—HTR7—epilepsy syndrome	7.64e-06	0.00446	CrCbGaD
Clomipramine—Imipramine—CHRM2—epilepsy syndrome	7.64e-06	0.00446	CrCbGaD
Clomipramine—Imipramine—HTR7—epilepsy syndrome	7.6e-06	0.00443	CrCbGaD
Clomipramine—Amitriptyline—CHRM2—epilepsy syndrome	7.59e-06	0.00443	CrCbGaD
Clomipramine—Amitriptyline—HTR7—epilepsy syndrome	7.56e-06	0.00441	CrCbGaD
Clomipramine—Promazine—ADRA2A—epilepsy syndrome	7.45e-06	0.00434	CrCbGaD
Clomipramine—Acepromazine—HTR2A—epilepsy syndrome	7.37e-06	0.0043	CrCbGaD
Clomipramine—Thioproperazine—HTR2A—epilepsy syndrome	7.2e-06	0.0042	CrCbGaD
Clomipramine—Adinazolam—CYP2C19—epilepsy syndrome	7.13e-06	0.00416	CrCbGaD
Clomipramine—Nortriptyline—SLC6A4—epilepsy syndrome	7.12e-06	0.00416	CrCbGaD
Clomipramine—Pipotiazine—HTR2A—epilepsy syndrome	7.09e-06	0.00413	CrCbGaD
Clomipramine—Chlorphenamine—CYP2D6—epilepsy syndrome	6.82e-06	0.00398	CrCbGaD
Clomipramine—Nortriptyline—CYP2C19—epilepsy syndrome	6.75e-06	0.00394	CrCbGaD
Clomipramine—Trimipramine—SLC6A4—epilepsy syndrome	6.71e-06	0.00391	CrCbGaD
Clomipramine—Chlorpromazine—ADRA2A—epilepsy syndrome	6.55e-06	0.00382	CrCbGaD
Clomipramine—Thioridazine—CYP2C19—epilepsy syndrome	6.51e-06	0.0038	CrCbGaD
Clomipramine—Pipotiazine—CYP2D6—epilepsy syndrome	6.48e-06	0.00378	CrCbGaD
Clomipramine—Amitriptyline—ADRA2A—epilepsy syndrome	6.48e-06	0.00378	CrCbGaD
Clomipramine—Headache—Diazepam—epilepsy syndrome	6.42e-06	8.54e-05	CcSEcCtD
Clomipramine—Chlorpromazine—BCHE—epilepsy syndrome	6.4e-06	0.00374	CrCbGaD
Clomipramine—Anxiety—Pregabalin—epilepsy syndrome	6.4e-06	8.52e-05	CcSEcCtD
Clomipramine—Diarrhoea—Clonazepam—epilepsy syndrome	6.4e-06	8.52e-05	CcSEcCtD
Clomipramine—Anaemia—Gabapentin—epilepsy syndrome	6.39e-06	8.51e-05	CcSEcCtD
Clomipramine—Doxepin—SLC6A4—epilepsy syndrome	6.39e-06	0.00373	CrCbGaD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.38e-06	8.49e-05	CcSEcCtD
Clomipramine—Hypotension—Valproic Acid—epilepsy syndrome	6.36e-06	8.47e-05	CcSEcCtD
Clomipramine—Asthenia—Carbamazepine—epilepsy syndrome	6.36e-06	8.47e-05	CcSEcCtD
Clomipramine—Trimipramine—CYP2C19—epilepsy syndrome	6.36e-06	0.00371	CrCbGaD
Clomipramine—Agitation—Gabapentin—epilepsy syndrome	6.36e-06	8.46e-05	CcSEcCtD
Clomipramine—Diarrhoea—Phenytoin—epilepsy syndrome	6.36e-06	8.46e-05	CcSEcCtD
Clomipramine—Discomfort—Pregabalin—epilepsy syndrome	6.34e-06	8.45e-05	CcSEcCtD
Clomipramine—Nausea—Fosphenytoin—epilepsy syndrome	6.34e-06	8.44e-05	CcSEcCtD
Clomipramine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.32e-06	8.41e-05	CcSEcCtD
Clomipramine—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.31e-06	8.4e-05	CcSEcCtD
Clomipramine—Vomiting—Felbamate—epilepsy syndrome	6.3e-06	8.39e-05	CcSEcCtD
Clomipramine—Dry mouth—Pregabalin—epilepsy syndrome	6.28e-06	8.36e-05	CcSEcCtD
Clomipramine—Pruritus—Carbamazepine—epilepsy syndrome	6.27e-06	8.35e-05	CcSEcCtD
Clomipramine—Rash—Felbamate—epilepsy syndrome	6.25e-06	8.32e-05	CcSEcCtD
Clomipramine—Eye disorder—Topiramate—epilepsy syndrome	6.25e-06	8.31e-05	CcSEcCtD
Clomipramine—Dermatitis—Felbamate—epilepsy syndrome	6.24e-06	8.31e-05	CcSEcCtD
Clomipramine—Malaise—Gabapentin—epilepsy syndrome	6.24e-06	8.3e-05	CcSEcCtD
Clomipramine—Tinnitus—Topiramate—epilepsy syndrome	6.23e-06	8.3e-05	CcSEcCtD
Clomipramine—Vertigo—Gabapentin—epilepsy syndrome	6.21e-06	8.27e-05	CcSEcCtD
Clomipramine—Headache—Felbamate—epilepsy syndrome	6.21e-06	8.27e-05	CcSEcCtD
Clomipramine—Confusional state—Pregabalin—epilepsy syndrome	6.21e-06	8.26e-05	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.2e-06	8.26e-05	CcSEcCtD
Clomipramine—Cardiac disorder—Topiramate—epilepsy syndrome	6.2e-06	8.26e-05	CcSEcCtD
Clomipramine—Flushing—Topiramate—epilepsy syndrome	6.2e-06	8.26e-05	CcSEcCtD
Clomipramine—Syncope—Gabapentin—epilepsy syndrome	6.2e-06	8.26e-05	CcSEcCtD
Clomipramine—Prochlorperazine—CYP2D6—epilepsy syndrome	6.19e-06	0.00361	CrCbGaD
Clomipramine—Leukopenia—Gabapentin—epilepsy syndrome	6.19e-06	8.24e-05	CcSEcCtD
Clomipramine—Dizziness—Clonazepam—epilepsy syndrome	6.18e-06	8.23e-05	CcSEcCtD
Clomipramine—Nausea—Vigabatrin—epilepsy syndrome	6.18e-06	8.22e-05	CcSEcCtD
Clomipramine—Vomiting—Zonisamide—epilepsy syndrome	6.17e-06	8.21e-05	CcSEcCtD
Clomipramine—Insomnia—Valproic Acid—epilepsy syndrome	6.16e-06	8.2e-05	CcSEcCtD
Clomipramine—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.16e-06	8.19e-05	CcSEcCtD
Clomipramine—Oedema—Pregabalin—epilepsy syndrome	6.16e-06	8.19e-05	CcSEcCtD
Clomipramine—Asthenia—Lamotrigine—epilepsy syndrome	6.15e-06	8.18e-05	CcSEcCtD
Clomipramine—Dizziness—Phenytoin—epilepsy syndrome	6.14e-06	8.18e-05	CcSEcCtD
Clomipramine—Rash—Zonisamide—epilepsy syndrome	6.12e-06	8.14e-05	CcSEcCtD
Clomipramine—Paraesthesia—Valproic Acid—epilepsy syndrome	6.11e-06	8.14e-05	CcSEcCtD
Clomipramine—Palpitations—Gabapentin—epilepsy syndrome	6.11e-06	8.14e-05	CcSEcCtD
Clomipramine—Dermatitis—Zonisamide—epilepsy syndrome	6.11e-06	8.14e-05	CcSEcCtD
Clomipramine—Dizziness—Oxcarbazepine—epilepsy syndrome	6.11e-06	8.13e-05	CcSEcCtD
Clomipramine—Nausea—Diazepam—epilepsy syndrome	6.08e-06	8.1e-05	CcSEcCtD
Clomipramine—Loss of consciousness—Gabapentin—epilepsy syndrome	6.08e-06	8.09e-05	CcSEcCtD
Clomipramine—Headache—Zonisamide—epilepsy syndrome	6.08e-06	8.09e-05	CcSEcCtD
Clomipramine—Dyspnoea—Valproic Acid—epilepsy syndrome	6.07e-06	8.08e-05	CcSEcCtD
Clomipramine—Diarrhoea—Carbamazepine—epilepsy syndrome	6.07e-06	8.07e-05	CcSEcCtD
Clomipramine—Angiopathy—Topiramate—epilepsy syndrome	6.07e-06	8.07e-05	CcSEcCtD
Clomipramine—Pruritus—Lamotrigine—epilepsy syndrome	6.06e-06	8.07e-05	CcSEcCtD
Clomipramine—Doxepin—CYP2C19—epilepsy syndrome	6.06e-06	0.00353	CrCbGaD
Clomipramine—Shock—Pregabalin—epilepsy syndrome	6.06e-06	8.06e-05	CcSEcCtD
Clomipramine—Somnolence—Valproic Acid—epilepsy syndrome	6.05e-06	8.06e-05	CcSEcCtD
Clomipramine—Immune system disorder—Topiramate—epilepsy syndrome	6.04e-06	8.04e-05	CcSEcCtD
Clomipramine—Nervous system disorder—Pregabalin—epilepsy syndrome	6.04e-06	8.04e-05	CcSEcCtD
Clomipramine—Cough—Gabapentin—epilepsy syndrome	6.04e-06	8.03e-05	CcSEcCtD
Clomipramine—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.03e-06	8.02e-05	CcSEcCtD
Clomipramine—Mediastinal disorder—Topiramate—epilepsy syndrome	6.02e-06	8.02e-05	CcSEcCtD
Clomipramine—Tachycardia—Pregabalin—epilepsy syndrome	6.01e-06	8e-05	CcSEcCtD
Clomipramine—Chills—Topiramate—epilepsy syndrome	6e-06	7.98e-05	CcSEcCtD
Clomipramine—Dyspepsia—Valproic Acid—epilepsy syndrome	5.99e-06	7.98e-05	CcSEcCtD
Clomipramine—Convulsion—Gabapentin—epilepsy syndrome	5.99e-06	7.98e-05	CcSEcCtD
Clomipramine—Skin disorder—Pregabalin—epilepsy syndrome	5.98e-06	7.96e-05	CcSEcCtD
Clomipramine—Perphenazine—CYP2C19—epilepsy syndrome	5.97e-06	0.00348	CrCbGaD
Clomipramine—Hypertension—Gabapentin—epilepsy syndrome	5.97e-06	7.95e-05	CcSEcCtD
Clomipramine—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.95e-06	7.92e-05	CcSEcCtD
Clomipramine—Vomiting—Clonazepam—epilepsy syndrome	5.95e-06	7.91e-05	CcSEcCtD
Clomipramine—Decreased appetite—Valproic Acid—epilepsy syndrome	5.92e-06	7.88e-05	CcSEcCtD
Clomipramine—Alopecia—Topiramate—epilepsy syndrome	5.91e-06	7.86e-05	CcSEcCtD
Clomipramine—Vomiting—Phenytoin—epilepsy syndrome	5.91e-06	7.86e-05	CcSEcCtD
Clomipramine—Rash—Clonazepam—epilepsy syndrome	5.9e-06	7.85e-05	CcSEcCtD
Clomipramine—Propiomazine—HTR2A—epilepsy syndrome	5.89e-06	0.00344	CrCbGaD
Clomipramine—Dermatitis—Clonazepam—epilepsy syndrome	5.89e-06	7.84e-05	CcSEcCtD
Clomipramine—Chest pain—Gabapentin—epilepsy syndrome	5.89e-06	7.84e-05	CcSEcCtD
Clomipramine—Arthralgia—Gabapentin—epilepsy syndrome	5.89e-06	7.84e-05	CcSEcCtD
Clomipramine—Myalgia—Gabapentin—epilepsy syndrome	5.89e-06	7.84e-05	CcSEcCtD
Clomipramine—Nausea—Felbamate—epilepsy syndrome	5.89e-06	7.84e-05	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.88e-06	7.82e-05	CcSEcCtD
Clomipramine—Vomiting—Oxcarbazepine—epilepsy syndrome	5.87e-06	7.82e-05	CcSEcCtD
Clomipramine—Fatigue—Valproic Acid—epilepsy syndrome	5.87e-06	7.81e-05	CcSEcCtD
Clomipramine—Anxiety—Gabapentin—epilepsy syndrome	5.87e-06	7.81e-05	CcSEcCtD
Clomipramine—Anorexia—Pregabalin—epilepsy syndrome	5.87e-06	7.81e-05	CcSEcCtD
Clomipramine—Desipramine—SLC6A4—epilepsy syndrome	5.86e-06	0.00342	CrCbGaD
Clomipramine—Dizziness—Carbamazepine—epilepsy syndrome	5.86e-06	7.8e-05	CcSEcCtD
Clomipramine—Diarrhoea—Lamotrigine—epilepsy syndrome	5.86e-06	7.8e-05	CcSEcCtD
Clomipramine—Headache—Clonazepam—epilepsy syndrome	5.86e-06	7.8e-05	CcSEcCtD
Clomipramine—Rash—Phenytoin—epilepsy syndrome	5.86e-06	7.8e-05	CcSEcCtD
Clomipramine—Mental disorder—Topiramate—epilepsy syndrome	5.86e-06	7.8e-05	CcSEcCtD
Clomipramine—Dermatitis—Phenytoin—epilepsy syndrome	5.85e-06	7.79e-05	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.85e-06	7.78e-05	CcSEcCtD
Clomipramine—Rash—Oxcarbazepine—epilepsy syndrome	5.83e-06	7.75e-05	CcSEcCtD
Clomipramine—Constipation—Valproic Acid—epilepsy syndrome	5.82e-06	7.75e-05	CcSEcCtD
Clomipramine—Pain—Valproic Acid—epilepsy syndrome	5.82e-06	7.75e-05	CcSEcCtD
Clomipramine—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.82e-06	7.75e-05	CcSEcCtD
Clomipramine—Headache—Phenytoin—epilepsy syndrome	5.82e-06	7.75e-05	CcSEcCtD
Clomipramine—Malnutrition—Topiramate—epilepsy syndrome	5.82e-06	7.75e-05	CcSEcCtD
Clomipramine—Discomfort—Gabapentin—epilepsy syndrome	5.82e-06	7.74e-05	CcSEcCtD
Clomipramine—Headache—Oxcarbazepine—epilepsy syndrome	5.79e-06	7.7e-05	CcSEcCtD
Clomipramine—Nausea—Zonisamide—epilepsy syndrome	5.76e-06	7.67e-05	CcSEcCtD
Clomipramine—Dry mouth—Gabapentin—epilepsy syndrome	5.76e-06	7.67e-05	CcSEcCtD
Clomipramine—Hypotension—Pregabalin—epilepsy syndrome	5.75e-06	7.66e-05	CcSEcCtD
Clomipramine—Flatulence—Topiramate—epilepsy syndrome	5.73e-06	7.63e-05	CcSEcCtD
Clomipramine—Tension—Topiramate—epilepsy syndrome	5.71e-06	7.6e-05	CcSEcCtD
Clomipramine—Dysgeusia—Topiramate—epilepsy syndrome	5.7e-06	7.58e-05	CcSEcCtD
Clomipramine—Confusional state—Gabapentin—epilepsy syndrome	5.69e-06	7.58e-05	CcSEcCtD
Clomipramine—Dizziness—Lamotrigine—epilepsy syndrome	5.67e-06	7.54e-05	CcSEcCtD
Clomipramine—Nervousness—Topiramate—epilepsy syndrome	5.65e-06	7.52e-05	CcSEcCtD
Clomipramine—Oedema—Gabapentin—epilepsy syndrome	5.65e-06	7.51e-05	CcSEcCtD
Clomipramine—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.65e-06	7.51e-05	CcSEcCtD
Clomipramine—Vomiting—Carbamazepine—epilepsy syndrome	5.64e-06	7.5e-05	CcSEcCtD
Clomipramine—Back pain—Topiramate—epilepsy syndrome	5.63e-06	7.49e-05	CcSEcCtD
Clomipramine—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.61e-06	7.47e-05	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.61e-06	7.47e-05	CcSEcCtD
Clomipramine—Muscle spasms—Topiramate—epilepsy syndrome	5.59e-06	7.45e-05	CcSEcCtD
Clomipramine—Rash—Carbamazepine—epilepsy syndrome	5.59e-06	7.44e-05	CcSEcCtD
Clomipramine—Dermatitis—Carbamazepine—epilepsy syndrome	5.59e-06	7.43e-05	CcSEcCtD
Clomipramine—Chlorprothixene—HTR2A—epilepsy syndrome	5.58e-06	0.00325	CrCbGaD
Clomipramine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.57e-06	7.41e-05	CcSEcCtD
Clomipramine—Insomnia—Pregabalin—epilepsy syndrome	5.57e-06	7.41e-05	CcSEcCtD
Clomipramine—Desipramine—CYP2C19—epilepsy syndrome	5.56e-06	0.00324	CrCbGaD
Clomipramine—Nausea—Clonazepam—epilepsy syndrome	5.55e-06	7.39e-05	CcSEcCtD
Clomipramine—Headache—Carbamazepine—epilepsy syndrome	5.55e-06	7.39e-05	CcSEcCtD
Clomipramine—Shock—Gabapentin—epilepsy syndrome	5.55e-06	7.39e-05	CcSEcCtD
Clomipramine—Nervous system disorder—Gabapentin—epilepsy syndrome	5.54e-06	7.37e-05	CcSEcCtD
Clomipramine—Paraesthesia—Pregabalin—epilepsy syndrome	5.53e-06	7.36e-05	CcSEcCtD
Clomipramine—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.53e-06	7.36e-05	CcSEcCtD
Clomipramine—Nausea—Phenytoin—epilepsy syndrome	5.52e-06	7.34e-05	CcSEcCtD
Clomipramine—Tachycardia—Gabapentin—epilepsy syndrome	5.51e-06	7.33e-05	CcSEcCtD
Clomipramine—Dyspnoea—Pregabalin—epilepsy syndrome	5.49e-06	7.31e-05	CcSEcCtD
Clomipramine—Nausea—Oxcarbazepine—epilepsy syndrome	5.49e-06	7.31e-05	CcSEcCtD
Clomipramine—Vision blurred—Topiramate—epilepsy syndrome	5.48e-06	7.3e-05	CcSEcCtD
Clomipramine—Skin disorder—Gabapentin—epilepsy syndrome	5.48e-06	7.3e-05	CcSEcCtD
Clomipramine—Nortriptyline—HTR2A—epilepsy syndrome	5.47e-06	0.00319	CrCbGaD
Clomipramine—Somnolence—Pregabalin—epilepsy syndrome	5.47e-06	7.28e-05	CcSEcCtD
Clomipramine—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.46e-06	7.26e-05	CcSEcCtD
Clomipramine—Tremor—Topiramate—epilepsy syndrome	5.45e-06	7.26e-05	CcSEcCtD
Clomipramine—Vomiting—Lamotrigine—epilepsy syndrome	5.45e-06	7.25e-05	CcSEcCtD
Clomipramine—Urticaria—Valproic Acid—epilepsy syndrome	5.41e-06	7.2e-05	CcSEcCtD
Clomipramine—Rash—Lamotrigine—epilepsy syndrome	5.4e-06	7.19e-05	CcSEcCtD
Clomipramine—Ill-defined disorder—Topiramate—epilepsy syndrome	5.4e-06	7.19e-05	CcSEcCtD
Clomipramine—Dermatitis—Lamotrigine—epilepsy syndrome	5.4e-06	7.18e-05	CcSEcCtD
Clomipramine—Promazine—CYP2C19—epilepsy syndrome	5.39e-06	0.00314	CrCbGaD
Clomipramine—Abdominal pain—Valproic Acid—epilepsy syndrome	5.38e-06	7.16e-05	CcSEcCtD
Clomipramine—Body temperature increased—Valproic Acid—epilepsy syndrome	5.38e-06	7.16e-05	CcSEcCtD
Clomipramine—Anorexia—Gabapentin—epilepsy syndrome	5.38e-06	7.16e-05	CcSEcCtD
Clomipramine—Anaemia—Topiramate—epilepsy syndrome	5.38e-06	7.16e-05	CcSEcCtD
Clomipramine—Headache—Lamotrigine—epilepsy syndrome	5.37e-06	7.15e-05	CcSEcCtD
Clomipramine—Decreased appetite—Pregabalin—epilepsy syndrome	5.35e-06	7.12e-05	CcSEcCtD
Clomipramine—Agitation—Topiramate—epilepsy syndrome	5.35e-06	7.12e-05	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.31e-06	7.07e-05	CcSEcCtD
Clomipramine—Fatigue—Pregabalin—epilepsy syndrome	5.31e-06	7.06e-05	CcSEcCtD
Clomipramine—Thioridazine—HTR2A—epilepsy syndrome	5.28e-06	0.00308	CrCbGaD
Clomipramine—Hypotension—Gabapentin—epilepsy syndrome	5.27e-06	7.02e-05	CcSEcCtD
Clomipramine—Nausea—Carbamazepine—epilepsy syndrome	5.27e-06	7.01e-05	CcSEcCtD
Clomipramine—Constipation—Pregabalin—epilepsy syndrome	5.26e-06	7.01e-05	CcSEcCtD
Clomipramine—Pain—Pregabalin—epilepsy syndrome	5.26e-06	7.01e-05	CcSEcCtD
Clomipramine—Malaise—Topiramate—epilepsy syndrome	5.25e-06	6.98e-05	CcSEcCtD
Clomipramine—Vertigo—Topiramate—epilepsy syndrome	5.23e-06	6.96e-05	CcSEcCtD
Clomipramine—Syncope—Topiramate—epilepsy syndrome	5.22e-06	6.95e-05	CcSEcCtD
Clomipramine—Leukopenia—Topiramate—epilepsy syndrome	5.21e-06	6.93e-05	CcSEcCtD
Clomipramine—Triflupromazine—ABCB1—epilepsy syndrome	5.2e-06	0.00303	CrCbGaD
Clomipramine—Trimipramine—HTR2A—epilepsy syndrome	5.15e-06	0.00301	CrCbGaD
Clomipramine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.14e-06	6.85e-05	CcSEcCtD
Clomipramine—Palpitations—Topiramate—epilepsy syndrome	5.14e-06	6.84e-05	CcSEcCtD
Clomipramine—Loss of consciousness—Topiramate—epilepsy syndrome	5.11e-06	6.81e-05	CcSEcCtD
Clomipramine—Insomnia—Gabapentin—epilepsy syndrome	5.11e-06	6.8e-05	CcSEcCtD
Clomipramine—Diazepam—CYP2C19—epilepsy syndrome	5.1e-06	0.00298	CrCbGaD
Clomipramine—Nausea—Lamotrigine—epilepsy syndrome	5.09e-06	6.77e-05	CcSEcCtD
Clomipramine—Cough—Topiramate—epilepsy syndrome	5.08e-06	6.76e-05	CcSEcCtD
Clomipramine—Feeling abnormal—Pregabalin—epilepsy syndrome	5.07e-06	6.75e-05	CcSEcCtD
Clomipramine—Paraesthesia—Gabapentin—epilepsy syndrome	5.07e-06	6.75e-05	CcSEcCtD
Clomipramine—Acepromazine—ALB—epilepsy syndrome	5.04e-06	0.00294	CrCbGaD
Clomipramine—Convulsion—Topiramate—epilepsy syndrome	5.04e-06	6.71e-05	CcSEcCtD
Clomipramine—Methotrimeprazine—HTR2A—epilepsy syndrome	5.04e-06	0.00294	CrCbGaD
Clomipramine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.03e-06	6.7e-05	CcSEcCtD
Clomipramine—Dyspnoea—Gabapentin—epilepsy syndrome	5.03e-06	6.7e-05	CcSEcCtD
Clomipramine—Hypertension—Topiramate—epilepsy syndrome	5.02e-06	6.69e-05	CcSEcCtD
Clomipramine—Somnolence—Gabapentin—epilepsy syndrome	5.02e-06	6.68e-05	CcSEcCtD
Clomipramine—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.02e-06	6.68e-05	CcSEcCtD
Clomipramine—Nortriptyline—CYP2D6—epilepsy syndrome	5.01e-06	0.00292	CrCbGaD
Clomipramine—Imipramine—SLC6A4—epilepsy syndrome	4.97e-06	0.0029	CrCbGaD
Clomipramine—Dyspepsia—Gabapentin—epilepsy syndrome	4.97e-06	6.61e-05	CcSEcCtD
Clomipramine—Promethazine—HTR2A—epilepsy syndrome	4.96e-06	0.00289	CrCbGaD
Clomipramine—Chest pain—Topiramate—epilepsy syndrome	4.95e-06	6.59e-05	CcSEcCtD
Clomipramine—Arthralgia—Topiramate—epilepsy syndrome	4.95e-06	6.59e-05	CcSEcCtD
Clomipramine—Myalgia—Topiramate—epilepsy syndrome	4.95e-06	6.59e-05	CcSEcCtD
Clomipramine—Amitriptyline—SLC6A4—epilepsy syndrome	4.94e-06	0.00288	CrCbGaD
Clomipramine—Anxiety—Topiramate—epilepsy syndrome	4.94e-06	6.57e-05	CcSEcCtD
Clomipramine—Thioproperazine—ALB—epilepsy syndrome	4.93e-06	0.00288	CrCbGaD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.92e-06	6.55e-05	CcSEcCtD
Clomipramine—Doxepin—HTR2A—epilepsy syndrome	4.91e-06	0.00287	CrCbGaD
Clomipramine—Decreased appetite—Gabapentin—epilepsy syndrome	4.91e-06	6.53e-05	CcSEcCtD
Clomipramine—Trifluoperazine—HTR2A—epilepsy syndrome	4.9e-06	0.00286	CrCbGaD
Clomipramine—Discomfort—Topiramate—epilepsy syndrome	4.89e-06	6.52e-05	CcSEcCtD
Clomipramine—Urticaria—Pregabalin—epilepsy syndrome	4.89e-06	6.51e-05	CcSEcCtD
Clomipramine—Asthenia—Valproic Acid—epilepsy syndrome	4.89e-06	6.5e-05	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.87e-06	6.49e-05	CcSEcCtD
Clomipramine—Fatigue—Gabapentin—epilepsy syndrome	4.87e-06	6.48e-05	CcSEcCtD
Clomipramine—Body temperature increased—Pregabalin—epilepsy syndrome	4.87e-06	6.48e-05	CcSEcCtD
Clomipramine—Abdominal pain—Pregabalin—epilepsy syndrome	4.87e-06	6.48e-05	CcSEcCtD
Clomipramine—Pipotiazine—ALB—epilepsy syndrome	4.85e-06	0.00283	CrCbGaD
Clomipramine—Dry mouth—Topiramate—epilepsy syndrome	4.85e-06	6.45e-05	CcSEcCtD
Clomipramine—Perphenazine—HTR2A—epilepsy syndrome	4.84e-06	0.00283	CrCbGaD
Clomipramine—Constipation—Gabapentin—epilepsy syndrome	4.83e-06	6.43e-05	CcSEcCtD
Clomipramine—Pain—Gabapentin—epilepsy syndrome	4.83e-06	6.43e-05	CcSEcCtD
Clomipramine—Thioridazine—CYP2D6—epilepsy syndrome	4.83e-06	0.00281	CrCbGaD
Clomipramine—Pruritus—Valproic Acid—epilepsy syndrome	4.82e-06	6.41e-05	CcSEcCtD
Clomipramine—Confusional state—Topiramate—epilepsy syndrome	4.79e-06	6.37e-05	CcSEcCtD
Clomipramine—Oedema—Topiramate—epilepsy syndrome	4.75e-06	6.32e-05	CcSEcCtD
Clomipramine—Imipramine—CYP2C19—epilepsy syndrome	4.72e-06	0.00275	CrCbGaD
Clomipramine—Trimipramine—CYP2D6—epilepsy syndrome	4.71e-06	0.00275	CrCbGaD
Clomipramine—Amitriptyline—CYP2C19—epilepsy syndrome	4.69e-06	0.00273	CrCbGaD
Clomipramine—Shock—Topiramate—epilepsy syndrome	4.67e-06	6.22e-05	CcSEcCtD
Clomipramine—Diarrhoea—Valproic Acid—epilepsy syndrome	4.66e-06	6.2e-05	CcSEcCtD
Clomipramine—Nervous system disorder—Topiramate—epilepsy syndrome	4.66e-06	6.2e-05	CcSEcCtD
Clomipramine—Feeling abnormal—Gabapentin—epilepsy syndrome	4.65e-06	6.19e-05	CcSEcCtD
Clomipramine—Thrombocytopenia—Topiramate—epilepsy syndrome	4.65e-06	6.19e-05	CcSEcCtD
Clomipramine—Tachycardia—Topiramate—epilepsy syndrome	4.64e-06	6.17e-05	CcSEcCtD
Clomipramine—Clobazam—ABCB1—epilepsy syndrome	4.63e-06	0.0027	CrCbGaD
Clomipramine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.62e-06	6.14e-05	CcSEcCtD
Clomipramine—Skin disorder—Topiramate—epilepsy syndrome	4.61e-06	6.14e-05	CcSEcCtD
Clomipramine—Methotrimeprazine—CYP2D6—epilepsy syndrome	4.61e-06	0.00269	CrCbGaD
Clomipramine—Hyperhidrosis—Topiramate—epilepsy syndrome	4.59e-06	6.11e-05	CcSEcCtD
Clomipramine—Promethazine—CYP2D6—epilepsy syndrome	4.54e-06	0.00265	CrCbGaD
Clomipramine—Hypersensitivity—Pregabalin—epilepsy syndrome	4.54e-06	6.04e-05	CcSEcCtD
Clomipramine—Anorexia—Topiramate—epilepsy syndrome	4.53e-06	6.03e-05	CcSEcCtD
Clomipramine—Desipramine—HTR2A—epilepsy syndrome	4.51e-06	0.00263	CrCbGaD
Clomipramine—Dizziness—Valproic Acid—epilepsy syndrome	4.5e-06	5.99e-05	CcSEcCtD
Clomipramine—Doxepin—CYP2D6—epilepsy syndrome	4.49e-06	0.00262	CrCbGaD
Clomipramine—Urticaria—Gabapentin—epilepsy syndrome	4.48e-06	5.97e-05	CcSEcCtD
Clomipramine—Abdominal pain—Gabapentin—epilepsy syndrome	4.46e-06	5.94e-05	CcSEcCtD
Clomipramine—Body temperature increased—Gabapentin—epilepsy syndrome	4.46e-06	5.94e-05	CcSEcCtD
Clomipramine—Hypotension—Topiramate—epilepsy syndrome	4.44e-06	5.91e-05	CcSEcCtD
Clomipramine—Perphenazine—CYP2D6—epilepsy syndrome	4.43e-06	0.00258	CrCbGaD
Clomipramine—Asthenia—Pregabalin—epilepsy syndrome	4.42e-06	5.88e-05	CcSEcCtD
Clomipramine—Promazine—HTR2A—epilepsy syndrome	4.37e-06	0.00255	CrCbGaD
Clomipramine—Pruritus—Pregabalin—epilepsy syndrome	4.36e-06	5.8e-05	CcSEcCtD
Clomipramine—Vomiting—Valproic Acid—epilepsy syndrome	4.33e-06	5.76e-05	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.33e-06	5.76e-05	CcSEcCtD
Clomipramine—Insomnia—Topiramate—epilepsy syndrome	4.3e-06	5.72e-05	CcSEcCtD
Clomipramine—Rash—Valproic Acid—epilepsy syndrome	4.29e-06	5.71e-05	CcSEcCtD
Clomipramine—Dermatitis—Valproic Acid—epilepsy syndrome	4.29e-06	5.71e-05	CcSEcCtD
Clomipramine—Headache—Valproic Acid—epilepsy syndrome	4.27e-06	5.68e-05	CcSEcCtD
Clomipramine—Paraesthesia—Topiramate—epilepsy syndrome	4.26e-06	5.68e-05	CcSEcCtD
Clomipramine—Dyspnoea—Topiramate—epilepsy syndrome	4.23e-06	5.64e-05	CcSEcCtD
Clomipramine—Somnolence—Topiramate—epilepsy syndrome	4.22e-06	5.62e-05	CcSEcCtD
Clomipramine—Diarrhoea—Pregabalin—epilepsy syndrome	4.21e-06	5.61e-05	CcSEcCtD
Clomipramine—Dyspepsia—Topiramate—epilepsy syndrome	4.18e-06	5.56e-05	CcSEcCtD
Clomipramine—Hypersensitivity—Gabapentin—epilepsy syndrome	4.16e-06	5.54e-05	CcSEcCtD
Clomipramine—Decreased appetite—Topiramate—epilepsy syndrome	4.13e-06	5.5e-05	CcSEcCtD
Clomipramine—Desipramine—CYP2D6—epilepsy syndrome	4.12e-06	0.0024	CrCbGaD
Clomipramine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.1e-06	5.46e-05	CcSEcCtD
Clomipramine—Fatigue—Topiramate—epilepsy syndrome	4.09e-06	5.45e-05	CcSEcCtD
Clomipramine—Dizziness—Pregabalin—epilepsy syndrome	4.07e-06	5.42e-05	CcSEcCtD
Clomipramine—Pain—Topiramate—epilepsy syndrome	4.06e-06	5.41e-05	CcSEcCtD
Clomipramine—Constipation—Topiramate—epilepsy syndrome	4.06e-06	5.41e-05	CcSEcCtD
Clomipramine—Asthenia—Gabapentin—epilepsy syndrome	4.05e-06	5.39e-05	CcSEcCtD
Clomipramine—Nausea—Valproic Acid—epilepsy syndrome	4.04e-06	5.38e-05	CcSEcCtD
Clomipramine—Pruritus—Gabapentin—epilepsy syndrome	3.99e-06	5.32e-05	CcSEcCtD
Clomipramine—Vomiting—Pregabalin—epilepsy syndrome	3.91e-06	5.21e-05	CcSEcCtD
Clomipramine—Feeling abnormal—Topiramate—epilepsy syndrome	3.91e-06	5.21e-05	CcSEcCtD
Clomipramine—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.88e-06	5.17e-05	CcSEcCtD
Clomipramine—Rash—Pregabalin—epilepsy syndrome	3.88e-06	5.17e-05	CcSEcCtD
Clomipramine—Dermatitis—Pregabalin—epilepsy syndrome	3.88e-06	5.16e-05	CcSEcCtD
Clomipramine—Diarrhoea—Gabapentin—epilepsy syndrome	3.86e-06	5.14e-05	CcSEcCtD
Clomipramine—Headache—Pregabalin—epilepsy syndrome	3.86e-06	5.13e-05	CcSEcCtD
Clomipramine—Chlorpromazine—HTR2A—epilepsy syndrome	3.84e-06	0.00224	CrCbGaD
Clomipramine—Imipramine—HTR2A—epilepsy syndrome	3.82e-06	0.00223	CrCbGaD
Clomipramine—Amitriptyline—HTR2A—epilepsy syndrome	3.8e-06	0.00222	CrCbGaD
Clomipramine—Urticaria—Topiramate—epilepsy syndrome	3.77e-06	5.02e-05	CcSEcCtD
Clomipramine—Body temperature increased—Topiramate—epilepsy syndrome	3.75e-06	5e-05	CcSEcCtD
Clomipramine—Abdominal pain—Topiramate—epilepsy syndrome	3.75e-06	5e-05	CcSEcCtD
Clomipramine—Nortriptyline—ALB—epilepsy syndrome	3.75e-06	0.00219	CrCbGaD
Clomipramine—Dizziness—Gabapentin—epilepsy syndrome	3.73e-06	4.97e-05	CcSEcCtD
Clomipramine—Nausea—Pregabalin—epilepsy syndrome	3.66e-06	4.87e-05	CcSEcCtD
Clomipramine—Chlorprothixene—ABCB1—epilepsy syndrome	3.64e-06	0.00212	CrCbGaD
Clomipramine—Vomiting—Gabapentin—epilepsy syndrome	3.59e-06	4.78e-05	CcSEcCtD
Clomipramine—Rash—Gabapentin—epilepsy syndrome	3.56e-06	4.74e-05	CcSEcCtD
Clomipramine—Dermatitis—Gabapentin—epilepsy syndrome	3.56e-06	4.73e-05	CcSEcCtD
Clomipramine—Headache—Gabapentin—epilepsy syndrome	3.54e-06	4.71e-05	CcSEcCtD
Clomipramine—Chlorpromazine—CYP2D6—epilepsy syndrome	3.51e-06	0.00205	CrCbGaD
Clomipramine—Hypersensitivity—Topiramate—epilepsy syndrome	3.5e-06	4.66e-05	CcSEcCtD
Clomipramine—Imipramine—CYP2D6—epilepsy syndrome	3.5e-06	0.00204	CrCbGaD
Clomipramine—Amitriptyline—CYP2D6—epilepsy syndrome	3.47e-06	0.00203	CrCbGaD
Clomipramine—Asthenia—Topiramate—epilepsy syndrome	3.41e-06	4.54e-05	CcSEcCtD
Clomipramine—Flurazepam—ABCB1—epilepsy syndrome	3.4e-06	0.00198	CrCbGaD
Clomipramine—Trimipramine—ABCB1—epilepsy syndrome	3.37e-06	0.00196	CrCbGaD
Clomipramine—Pruritus—Topiramate—epilepsy syndrome	3.36e-06	4.47e-05	CcSEcCtD
Clomipramine—Nausea—Gabapentin—epilepsy syndrome	3.35e-06	4.46e-05	CcSEcCtD
Clomipramine—Diarrhoea—Topiramate—epilepsy syndrome	3.25e-06	4.33e-05	CcSEcCtD
Clomipramine—Promethazine—ABCB1—epilepsy syndrome	3.24e-06	0.00189	CrCbGaD
Clomipramine—Doxepin—ABCB1—epilepsy syndrome	3.21e-06	0.00187	CrCbGaD
Clomipramine—Trifluoperazine—ABCB1—epilepsy syndrome	3.2e-06	0.00187	CrCbGaD
Clomipramine—Dizziness—Topiramate—epilepsy syndrome	3.14e-06	4.18e-05	CcSEcCtD
Clomipramine—Vomiting—Topiramate—epilepsy syndrome	3.02e-06	4.02e-05	CcSEcCtD
Clomipramine—Rash—Topiramate—epilepsy syndrome	2.99e-06	3.99e-05	CcSEcCtD
Clomipramine—Dermatitis—Topiramate—epilepsy syndrome	2.99e-06	3.98e-05	CcSEcCtD
Clomipramine—Headache—Topiramate—epilepsy syndrome	2.98e-06	3.96e-05	CcSEcCtD
Clomipramine—Desipramine—ABCB1—epilepsy syndrome	2.94e-06	0.00172	CrCbGaD
Clomipramine—Diazepam—ALB—epilepsy syndrome	2.83e-06	0.00165	CrCbGaD
Clomipramine—Nausea—Topiramate—epilepsy syndrome	2.82e-06	3.75e-05	CcSEcCtD
Clomipramine—Diazepam—ABCB1—epilepsy syndrome	2.7e-06	0.00158	CrCbGaD
Clomipramine—Chlorpromazine—ALB—epilepsy syndrome	2.63e-06	0.00153	CrCbGaD
Clomipramine—Amitriptyline—ALB—epilepsy syndrome	2.6e-06	0.00152	CrCbGaD
Clomipramine—Chlorpromazine—ABCB1—epilepsy syndrome	2.51e-06	0.00146	CrCbGaD
Clomipramine—Imipramine—ABCB1—epilepsy syndrome	2.5e-06	0.00146	CrCbGaD
Clomipramine—Amitriptyline—ABCB1—epilepsy syndrome	2.48e-06	0.00145	CrCbGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.96e-07	3.43e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—FYN—epilepsy syndrome	9.9e-07	3.41e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—H2AFX—epilepsy syndrome	9.87e-07	3.39e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	9.85e-07	3.39e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—SLC2A1—epilepsy syndrome	9.85e-07	3.39e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MEF2C—epilepsy syndrome	9.85e-07	3.39e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	9.81e-07	3.38e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	9.81e-07	3.37e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—S100B—epilepsy syndrome	9.78e-07	3.36e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	9.78e-07	3.36e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.76e-07	3.36e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PLCB1—epilepsy syndrome	9.74e-07	3.35e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PRKCB—epilepsy syndrome	9.74e-07	3.35e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—POMC—epilepsy syndrome	9.72e-07	3.34e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—TH—epilepsy syndrome	9.71e-07	3.34e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6ST—epilepsy syndrome	9.7e-07	3.34e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SOCS3—epilepsy syndrome	9.68e-07	3.33e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CDC42—epilepsy syndrome	9.66e-07	3.32e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	9.63e-07	3.31e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	9.57e-07	3.29e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.56e-07	3.29e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	9.54e-07	3.28e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—YWHAZ—epilepsy syndrome	9.52e-07	3.27e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCL2—epilepsy syndrome	9.51e-07	3.27e-05	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—AKT1—epilepsy syndrome	9.47e-07	3.26e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	9.41e-07	3.24e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	9.41e-07	3.24e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	9.4e-07	3.23e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CASP3—epilepsy syndrome	9.38e-07	3.23e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	9.36e-07	3.22e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	9.35e-07	3.22e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	9.31e-07	3.2e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—BCHE—epilepsy syndrome	9.27e-07	3.19e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GPX1—epilepsy syndrome	9.16e-07	3.15e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	9.16e-07	3.15e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	9.12e-07	3.14e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—JUN—epilepsy syndrome	9.11e-07	3.13e-05	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.1e-07	3.13e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	9.08e-07	3.13e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—BCHE—epilepsy syndrome	9.05e-07	3.11e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	8.96e-07	3.08e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	8.9e-07	3.06e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—POMC—epilepsy syndrome	8.87e-07	3.05e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MMP9—epilepsy syndrome	8.87e-07	3.05e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	8.84e-07	3.04e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	8.84e-07	3.04e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	8.81e-07	3.03e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	8.79e-07	3.02e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	8.75e-07	3.01e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	8.72e-07	3e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—TH—epilepsy syndrome	8.71e-07	3e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCL2—epilepsy syndrome	8.68e-07	2.99e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	8.63e-07	2.97e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	8.6e-07	2.96e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—AKT1—epilepsy syndrome	8.6e-07	2.96e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—FGF2—epilepsy syndrome	8.59e-07	2.96e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.58e-07	2.95e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	8.57e-07	2.95e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	8.56e-07	2.95e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	8.55e-07	2.94e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	8.54e-07	2.94e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	8.53e-07	2.93e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	8.51e-07	2.93e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	8.51e-07	2.93e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—TH—epilepsy syndrome	8.51e-07	2.93e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	8.5e-07	2.92e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	8.49e-07	2.92e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—SRC—epilepsy syndrome	8.49e-07	2.92e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	8.44e-07	2.9e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.38e-07	2.88e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	8.33e-07	2.87e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—VEGFA—epilepsy syndrome	8.27e-07	2.84e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	8.27e-07	2.84e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	8.25e-07	2.84e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	8.25e-07	2.84e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	8.17e-07	2.81e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—SRC—epilepsy syndrome	8.17e-07	2.81e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	8.16e-07	2.81e-05	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—AKT1—epilepsy syndrome	8.14e-07	2.8e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	8.13e-07	2.8e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—HMOX1—epilepsy syndrome	8.1e-07	2.79e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	8.04e-07	2.77e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	8.04e-07	2.77e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AGT—epilepsy syndrome	8.03e-07	2.76e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—TH—epilepsy syndrome	8.02e-07	2.76e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CAT—epilepsy syndrome	7.99e-07	2.75e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RELA—epilepsy syndrome	7.98e-07	2.74e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—VEGFA—epilepsy syndrome	7.96e-07	2.74e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	7.95e-07	2.74e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—APOE—epilepsy syndrome	7.87e-07	2.71e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	7.86e-07	2.7e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	7.84e-07	2.7e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	7.82e-07	2.69e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	7.82e-07	2.69e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MTOR—epilepsy syndrome	7.82e-07	2.69e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	7.79e-07	2.68e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	7.78e-07	2.68e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ABCB1—epilepsy syndrome	7.78e-07	2.68e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.64e-07	2.63e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	7.62e-07	2.62e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	7.52e-07	2.59e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	7.44e-07	2.56e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	7.39e-07	2.54e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	7.38e-07	2.54e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	7.28e-07	2.5e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	7.27e-07	2.5e-05	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—AKT1—epilepsy syndrome	7.26e-07	2.5e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	7.25e-07	2.49e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	7.23e-07	2.49e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	7.23e-07	2.49e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GPX1—epilepsy syndrome	7.23e-07	2.49e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	7.22e-07	2.48e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CASP3—epilepsy syndrome	7.19e-07	2.48e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CAT—epilepsy syndrome	7.18e-07	2.47e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	7.16e-07	2.46e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	7.14e-07	2.46e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	7.1e-07	2.44e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	7.09e-07	2.44e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	7.08e-07	2.44e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CAT—epilepsy syndrome	7e-07	2.41e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	7e-07	2.41e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—JUN—epilepsy syndrome	6.99e-07	2.4e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	6.98e-07	2.4e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	6.89e-07	2.37e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	6.82e-07	2.35e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	6.81e-07	2.34e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	6.8e-07	2.34e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	6.79e-07	2.34e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—TH—epilepsy syndrome	6.79e-07	2.34e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—POMC—epilepsy syndrome	6.76e-07	2.33e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	6.73e-07	2.31e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	6.72e-07	2.31e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	6.72e-07	2.31e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	6.69e-07	2.3e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	6.69e-07	2.3e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.68e-07	2.3e-05	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	6.63e-07	2.28e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CAT—epilepsy syndrome	6.6e-07	2.27e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	6.59e-07	2.27e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	6.58e-07	2.26e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	6.57e-07	2.26e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	6.56e-07	2.26e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.51e-07	2.24e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	6.49e-07	2.23e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	6.45e-07	2.22e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	6.42e-07	2.21e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	6.38e-07	2.19e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AGT—epilepsy syndrome	6.34e-07	2.18e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GPX1—epilepsy syndrome	6.33e-07	2.18e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	6.33e-07	2.18e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SRC—epilepsy syndrome	6.27e-07	2.16e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	6.21e-07	2.14e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—APOE—epilepsy syndrome	6.21e-07	2.14e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	6.21e-07	2.14e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	6.21e-07	2.14e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	6.18e-07	2.13e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ALB—epilepsy syndrome	6.16e-07	2.12e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	6.11e-07	2.1e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	6.08e-07	2.09e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	6.02e-07	2.07e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	5.97e-07	2.05e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	5.88e-07	2.02e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	5.87e-07	2.02e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	5.76e-07	1.98e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	5.72e-07	1.97e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AGT—epilepsy syndrome	5.69e-07	1.96e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	5.67e-07	1.95e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	5.65e-07	1.94e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.6e-07	1.93e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CAT—epilepsy syndrome	5.59e-07	1.92e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOE—epilepsy syndrome	5.58e-07	1.92e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.57e-07	1.92e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	5.57e-07	1.92e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AGT—epilepsy syndrome	5.55e-07	1.91e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	5.53e-07	1.9e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	5.5e-07	1.89e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOE—epilepsy syndrome	5.44e-07	1.87e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	5.44e-07	1.87e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	5.39e-07	1.86e-05	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	5.35e-07	1.84e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—POMC—epilepsy syndrome	5.34e-07	1.84e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.32e-07	1.83e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	5.3e-07	1.82e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—AKT1—epilepsy syndrome	5.28e-07	1.82e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.26e-07	1.81e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TH—epilepsy syndrome	5.24e-07	1.8e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AGT—epilepsy syndrome	5.23e-07	1.8e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	5.15e-07	1.77e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.13e-07	1.76e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	5.1e-07	1.75e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AKT1—epilepsy syndrome	5.08e-07	1.75e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	5.06e-07	1.74e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	5.01e-07	1.72e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	5e-07	1.72e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	5e-07	1.72e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	4.86e-07	1.67e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—POMC—epilepsy syndrome	4.79e-07	1.65e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—POMC—epilepsy syndrome	4.68e-07	1.61e-05	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.64e-07	1.6e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	4.64e-07	1.6e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	4.62e-07	1.59e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	4.6e-07	1.58e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	4.55e-07	1.57e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	4.5e-07	1.55e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	4.47e-07	1.54e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AGT—epilepsy syndrome	4.43e-07	1.53e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—POMC—epilepsy syndrome	4.41e-07	1.52e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.37e-07	1.5e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ALB—epilepsy syndrome	4.37e-07	1.5e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	4.35e-07	1.5e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOE—epilepsy syndrome	4.34e-07	1.49e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.32e-07	1.48e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ALB—epilepsy syndrome	4.26e-07	1.47e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—epilepsy syndrome	4.26e-07	1.46e-05	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.22e-07	1.45e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	4.22e-07	1.45e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.2e-07	1.44e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	4.19e-07	1.44e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	4.07e-07	1.4e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.02e-07	1.38e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	4.01e-07	1.38e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	3.96e-07	1.36e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	3.9e-07	1.34e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.9e-07	1.34e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	3.9e-07	1.34e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	3.84e-07	1.32e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	3.82e-07	1.31e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—POMC—epilepsy syndrome	3.73e-07	1.28e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	3.73e-07	1.28e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	3.65e-07	1.25e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	3.56e-07	1.22e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	3.55e-07	1.22e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.51e-07	1.21e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.42e-07	1.18e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ALB—epilepsy syndrome	3.4e-07	1.17e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.35e-07	1.15e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	2.98e-07	1.02e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.88e-07	9.91e-06	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	2.87e-07	9.87e-06	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	2.71e-07	9.32e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.63e-07	9.03e-06	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	2.49e-07	8.57e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.3e-07	7.9e-06	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	2.27e-07	7.8e-06	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AKT1—epilepsy syndrome	2.14e-07	7.36e-06	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.92e-07	6.61e-06	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.87e-07	6.45e-06	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.77e-07	6.08e-06	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.5e-07	5.15e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.15e-07	3.97e-06	CbGpPWpGaD
